Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis

BACKGROUND: Transthyretin cardiac amyloidosis (ATTR‐CMP) is an increasingly recognized and treatable cause of heart failure with preserved ejection fraction. Multimodality cardiac imaging is recommended for ATTR‐CMP diagnosis, but its cost‐effectiveness in current clinical practice has not been well...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Yin, Pandya, Ankur, Cuddy, Sarah A. M., Singh, Amitoj, Singh, Avinainder, Dorbala, Sharmila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683684/
https://www.ncbi.nlm.nih.gov/pubmed/36102240
http://dx.doi.org/10.1161/JAHA.122.026308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683684/
https://www.ncbi.nlm.nih.gov/pubmed/36102240
http://dx.doi.org/10.1161/JAHA.122.026308

Ejemplares similares